New ADA policy on opioids supports mandates on prescription limits and continuing education in what could be the first of its kind among major health care professional organizations.
The American Dental Association has developed new recommendations for evaluating potentially malignant disorders in the oral cavity. The guideline comes after an expert panel convened by the ADA Council on Scientific Affairs and the Center for Evidence-Based Dentistry conducted a systematic review of the best available evidence.
ADA identified 19.6 million potential patients who believe in the importance of dental visits but for various reasons are not following through to make an appointment.
The ADA Bylaws give the Board of Trustees the power to elect Honorary Members of the Association. The Board, in turn, has guidelines and procedures governing the nomination and selection process for awarding ADA Honorary Membership. These guidelines appear in the Organization and Rules of the Board of Trustees and are reprinted below. Honorary Membership: […]
The Association is requesting that Congress include provisions of H.R. 372 — a bill that would amend the McCarran-Ferguson Act of 1945 — in future legislation affecting the Affordable Care Act.
Washington — As the new Congress considers replacement legislation for the Affordable Care Act, the Association on Jan. 13 shared its priorities with the new administration. In a letter to Ways and Means Committee Chair Kevin Brady, R-Texas, and Ranking Member Richard Neal, D-Mass., ADA President Gary L. Roberts and Executive Director Kathleen T. O’Loughlin […]
By Michelle Manchir A new resource is available for dental professionals who whiten patients’ teeth. In January, the American National Standards Institute approved an ADA-developed standard regarding products for external tooth bleaching. ANSI/ADA Standard No. 136 addresses requirements and test methods for products intended for external bleaching of natural teeth by chemical means, and is […]
Silver Spring, Md. — The Food and Drug Administration Sept. 30 approved a supplemental premarket application for a new indication for Allergan’s Juvederm Ultra XC. The supplemental approval for Juvederm Ultra XC, an injectable hyaluronic acid/lidocaine gel combination, is for injection into the lips and perioral area for lip augmentation in adults 21 years of […]